| World Journal of Nephrology and Urology, ISSN 1927-1239 print, 1927-1247 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, World J Nephrol Urol and Elmer Press Inc |
| Journal website https://www.wjnu.org |
Letter to the Editor
Volume 9, Number 2, December 2020, pages 52-55
Renal Injury in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: An Additional Concern to the Clinicians
Table
| Reference | Group | Patients number | Chronic kidney disease number (%) | Creatinine (µmol/L)a | BUN (mmol/L)a | % of patients with abnormal kidney function |
|---|---|---|---|---|---|---|
| aData were presented as mean (SD) or median (IQR); bSevere: patients admitted to the intensive care unit (ICU). COVID-19: coronavirus disease 2019; SD: standard deviation; IQR: interquartile range; BUN: blood urea nitrogen; AKI: acute kidney injury; NA: data were not available. | ||||||
| Arentz et al, 2020 [11] | Hospitalized | 21 | 10 (47.6) | 128.2 (8.8 - 397.8) | NA | NA |
| Chan et al, 2020 [10] | Non-AKI | 2,158 | 81 (4) | 70.7 (61 - 80) | 13 (10 - 19) | NA |
| Presence of AKI | 1,835 | 339 (18) | 129.9 (93 - 212) | 31 (18 - 51) | NA | |
| Chen et al, 2020 [2] | Hospitalized | 99 | NA | 75.6 (25) | 5.9 (2.6) | Creatinine: 3; BUN: 6 |
| Cheng et al, 2020 [4] | Hospitalized | 701 | 36 (5.1) | 77 (31) | 5.7 (3.9) | Creatinine: 14.4; BUN: 13.1 |
| Guan et al, 2020 [5] | Severeb | 173 | 3 (1.7) | NA | NA | 4.3 |
| Non-severe | 926 | 5 (0.5) | NA | NA | 1.0 | |
| Huang et al, 2020 [12] | Severeb | 13 | 0 | 79 (53.1 - 92.7) | NA | 15 |
| Non-severe | 28 | 1 (4) | 73.3 (57.5 - 84.7) | NA | 7 | |
| Liu et al, 2020 [6] | Severeb | 13 | NA | 74.2 (28.3) | 3.3 (2.7 - 3.7) | NA |
| Mild | 27 | NA | 64 (13.3) | 3.2 (2.5 - 4.4) | NA | |
| Mo et al, 2020 [13] | Severeb | 85 | 4 (4.47) | 79 (65 - 96) | NA | NA |
| Mild | 70 | 2 (2.9) | 65 (58 - 78) | NA | NA | |
| Regina et al, 2020 [14] | No-ventilation | 163 | 26 (16) | 88.5 (70 - 112.7) | NA | NA |
| Ventilation | 37 | 2 (5.4) | 97 (82 - 127) | NA | NA | |
| Rubin et al, 2020 [15] | Severeb | 71 | 4 (6) | 115.6 | 10.1 | NA |
| Shi et al, 2020 [16] | Hospitalized | 81 | 75.4 (29.8) | NA | NA | |
| Wang et al, 2020 [7] | Severeb | 36 | 2 (5.6) | 80 (66 - 106) | 5.9 (4.3 - 9.6) | NA |
| Non-severe | 102 | 2 (2.0) | 71 (58 - 84) | 4 (3.1 - 5.1) | NA | |
| Xia et al, 2020 [9] | Presence of AKI | 41 | 41 (100) | 104 (74 - 188.5) | 12.5 (8.6 - 27.8) | NA |
| Non-AKI | 40 | 65.5 (48 - 80) | 7.1 (5.5 - 10.6) | NA | ||
| Xu et al, 2020 [8] | Hospitalized | 62 | NA | 72 (61 - 84) | NA | 5 |
| Yang et al, 2020 [17] | Survivors | 20 | 12 (60) | 80.7 (32.3) | NA | NA |
| Non-survivors | 32 | 3 (9.4) | 76.3 (24.4) | NA | NA | |
| Zhao et al, 2020 [18] | Severeb | 30 | 1 (3.3) | NA | NA | 16.7 |
| Mild | 61 | 0 | NA | NA | 0 | |